{"id":838979,"date":"2026-08-02T02:49:11","date_gmt":"2026-08-02T02:49:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/838979\/"},"modified":"2026-08-02T02:49:11","modified_gmt":"2026-08-02T02:49:11","slug":"first-treatment-for-rare-brain-cancer-in-20-years-lands-on-pbs","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/838979\/","title":{"rendered":"First treatment for rare brain cancer in 20 years lands on PBS"},"content":{"rendered":"<p>The first breakthrough <a href=\"https:\/\/www.nine.com.au\/topic\/health-hq3\" class=\"sc-eRZcwA dNXoqI\" rel=\"nofollow noopener\" target=\"_blank\">treatment<\/a> for a rare, incurable brain <a href=\"https:\/\/www.nine.com.au\/topic\/cancer-5vm\" class=\"sc-eRZcwA dNXoqI\" rel=\"nofollow noopener\" target=\"_blank\">cancer<\/a> in more than 20 years will be listed on the PBS this week, saving patients tens of thousands of dollars.<\/p>\n<p>The drug vorasdienib, sold as Voranigo, will be listed on the subsidised scheme for people living with IDH-mutant astrocytoma or oligodendroglioma.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/08\/2443fde3d0fb7cc7867c69edf88fbd9e39006882b986ac69d3797516f828084a.jpeg\"  width=\"100%\"\/><\/p>\n<p class=\"_0b53bae146db0b62 _7475dd3391ee1518\" style=\"--text-color:var(--color-text-secondary)\">A new drug for a rare brain cancer has been listed on the PBS.\u00a0Mohammed Haneefa Nizamudeen<\/p>\n<p>These brain tumours, while rare, are the most common malignant primary brain tumours in adults under 50, and affect an estimated 3230 Australians, according to Voranigo manufacturers Servier.<\/p>\n<p>Patients are typically diagnosed between the ages of 20 and 45, with symptoms escalating over many years including seizures, cognitive changes, physical disability, and loss of independence.<\/p>\n<p>Prior to this new drug being approved, patient options were limited to surgery, ongoing monitoring, and radiotherapy or chemotherapy to slow its progression.<\/p>\n<p>There is no cure.<\/p>\n<p>The PBS listing means patients will pay a maximum of $25 per script, or $7.70 with a concession card, for a medicine that would otherwise cost tens of thousands of dollars a month.<\/p>\n<p>Vorasidenib can be used to treat cancers with mutations in the IDH1 or IDH 2 genes that cause abnormal proteins to form, which in turn contribute to cancer growth.<\/p>\n<p>The drug blocks the mutated proteins, which can slow or stop the cancer from growing.<\/p>\n<p>\u201cThis is the first new treatment in 20 years being listed for a rare brain cancer, which can slow disease progression,\u201d Health Minister Mark Butler said.<\/p>\n<p>\u201cListing Voranigo will benefit around 135 Australians diagnosed with this rare, incurable brain cancer each year, offering these patients a treatment option that can give them precious time.\u201d<\/p>\n<p>Butler said without a PBS listing, patients would have to pay up to $28,000 for 30 days worth of the treatment.<\/p>\n<p>\u201cFor people living with IDH-mutant glioma, managing the disease involves making complex treatment decisions over many years,\u201d Peter MacCallum Cancer Centre medical oncologist Associate Professor Jim Whittle said.<\/p>\n<p>\u201cCaring for these patients often involves balancing long-term disease control with preserving neurological function and quality of life.\u201d<\/p>\n<p>He said the addition of vorasidenib to the PBS provided more choice to patients battling the disease.<\/p>\n<p>Australian Brain Tumour Collaborative spokesperson Craig Cardinal said the listing was a \u201csignificant milestone\u201d.<\/p>\n<p>\u201cAccess to treatment is only one part of the journey.,\u201d he said.<\/p>\n<p>\u201cPeople living with brain cancer and their families also need coordinated multidisciplinary care, psychosocial support and practical services throughout every stage of their diagnosis.\u201d<\/p>\n<p>Servier Australia and New Zealand general manager M\u00e9lanie Chamaux said the company was proud to see Voranigo listed on the PBS.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/08\/65e37722988e33a7042b7371da680cd514e5c9d7.jpeg\"  width=\"100%\"\/><\/p>\n<p class=\"_0b53bae146db0b62 _7475dd3391ee1518\" style=\"--text-color:var(--color-text-secondary)\">The drug will allow more options for doctors and patients.\u00a0Getty<\/p>\n<p>\u201cThe listing represents a collective achievement of the healthcare system recognising therapeutic progress and the meaningful difference innovative medicines can make for patients, their families and the broader community,\u201d she said.<\/p>\n<p>\u201cWe hope this milestone brings renewed confidence and optimism to those facing the challenges of this disease.\u201d<\/p>\n<p>Vorasdienib can result in increased liver enzymes, with other side effects including fatigue, headache, diarrhoea, nausea, muscle ages, and stiffness.<\/p>\n<p>Servier guidelines say liver function should be monitored before and throughout treatment.<\/p>\n<p>Patients should consult their specialist about their treatment options.<\/p>\n","protected":false},"excerpt":{"rendered":"The first breakthrough treatment for a rare, incurable brain cancer in more than 20 years will be listed&hellip;\n","protected":false},"author":2,"featured_media":838980,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[64,63,137],"class_list":["post-838979","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-au","tag-australia","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/838979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=838979"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/838979\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/838980"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=838979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=838979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=838979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}